219 related articles for article (PubMed ID: 20223651)
1. Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivo.
Fukui M; Yamabe N; Zhu BT
Eur J Cancer; 2010 Jul; 46(10):1882-91. PubMed ID: 20223651
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol augments paclitaxel treatment in MDA-MB-231 and paclitaxel-resistant MDA-MB-231 breast cancer cells.
Sprouse AA; Herbert BS
Anticancer Res; 2014 Oct; 34(10):5363-74. PubMed ID: 25275030
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxel-induced apoptosis.
Rigolio R; Miloso M; Nicolini G; Villa D; Scuteri A; Simone M; Tredici G
Neurochem Int; 2005 Feb; 46(3):205-11. PubMed ID: 15670636
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo.
Garvin S; Ollinger K; Dabrosin C
Cancer Lett; 2006 Jan; 231(1):113-22. PubMed ID: 16356836
[TBL] [Abstract][Full Text] [Related]
5. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin αvβ3.
Hsieh TC; Wong C; John Bennett D; Wu JM
Int J Cancer; 2011 Dec; 129(11):2732-43. PubMed ID: 21225623
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines.
Mao QQ; Bai Y; Lin YW; Zheng XY; Qin J; Yang K; Xie LP
Mol Nutr Food Res; 2010 Nov; 54(11):1574-84. PubMed ID: 20521268
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction.
Flores ML; Castilla C; Ávila R; Ruiz-Borrego M; Sáez C; Japón MA
Breast Cancer Res Treat; 2012 Jun; 133(3):917-28. PubMed ID: 22076480
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with mitogen-activated protein kinase signaling and protein translation.
Alkhalaf M
Eur J Cancer Prev; 2007 Aug; 16(4):334-41. PubMed ID: 17554206
[TBL] [Abstract][Full Text] [Related]
9. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
Kuo PL; Chen CY; Hsu YL
Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
[TBL] [Abstract][Full Text] [Related]
10. Involvement of p21Waf1 in mediating inhibition of paclitaxel-induced apoptosis by epidermal growth factor in MDA-MB-468 human breast cancer cells.
Fang M; Liu B; Schmidt M; Lu Y; Mendelsohn J; Fan Z
Anticancer Res; 2000; 20(1A):103-11. PubMed ID: 10769641
[TBL] [Abstract][Full Text] [Related]
11. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
Shi YK; Li ZH; Han XQ; Yi JH; Wang ZH; Hou JL; Feng CR; Fang QH; Wang HH; Zhang PF; Wang FS; Shen J; Wang P
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signalling.
Fulda S; Debatin KM
Eur J Cancer; 2005 Mar; 41(5):786-98. PubMed ID: 15763656
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.
Wesierska-Gadek J; Kramer MP; Maurer M
Food Chem Toxicol; 2008 Apr; 46(4):1327-33. PubMed ID: 17933449
[TBL] [Abstract][Full Text] [Related]
14. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
[TBL] [Abstract][Full Text] [Related]
15. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells.
Zhu X; Wang K; Zhang K; Zhu L; Zhou F
Toxicol Lett; 2014 May; 227(1):65-73. PubMed ID: 24680927
[TBL] [Abstract][Full Text] [Related]
16. Riccardin D, a macrocyclic bisbibenzy, inhibits human breast cancer growth through the suppression of telomerase activity.
Sun CC; Xu HM; Yuan Y; Gao ZH; Lou HX; Qu XJ
Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):488-98. PubMed ID: 24836118
[TBL] [Abstract][Full Text] [Related]
17. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
Han GZ; Liu ZJ; Shimoi K; Zhu BT
Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
[TBL] [Abstract][Full Text] [Related]
18. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effect of resveratrol in pancreatic cancer cells.
Cui J; Sun R; Yu Y; Gou S; Zhao G; Wang C
Phytother Res; 2010 Nov; 24(11):1637-44. PubMed ID: 21031621
[TBL] [Abstract][Full Text] [Related]
20. The effect of seal oil on paclitaxel induced cytotoxicity and apoptosis in breast carcinoma MCF-7 and MDA-MB-231 cell lines.
Wang Z; Butt K; Wang L; Liu H
Nutr Cancer; 2007; 58(2):230-8. PubMed ID: 17640170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
